Delivery Order 36F79719D0217-36C26223F0437
Award Date 5/15/23
Potential Completion Date 9/30/23
Potential Value $102K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Carrollton, TX 75010, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded a $15,090.88 delivery order to Janssen Biotech, Inc. under the Pharmaceuticals and Drugs Federal Supply Schedule contract (FSS-61-IB) for BALVERSA 4 MG. The firm fixed price order is for the delivery of the specified pharmaceutical product to a location in Carrollton, Texas, with performance to be completed by November 13, 2020. No set-aside designation was applied to this order placed...
- The Department of Veterans Affairs Veterans Health Administration awarded a $17,046 delivery order against GSA Schedule Pharmaceuticals and Drugs (FSS-61-IB) to Janssen Biotech, Inc. The order is to provide BALVERSA 4MG for use by Veterans Integrated Service Network 5 from August 17-21, 2023. As the VA-VHA's pharmaceutical procurement vehicle, FSS-61-IB facilitates access to medications supporting treatment programs for veterans nationwide. Janssen will deliver the ordered product to a...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded a $17,046 delivery order to Janssen Biotech, Inc. under the company's Pharmaceuticals and Drugs GSA Schedule contract. The order is for BALVERSA 4MG and will be fulfilled from July 18-20, 2023 with performance taking place in Carrollton, Texas. Janssen Biotech will provide the specified oncology drug to VA-VHA under a firm fixed price arrangement. As one of the largest health care...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded a $17,046 firm fixed price delivery order against GSA Schedule Pharmaceuticals and Drugs (FSS-61-IB) to Janssen Biotech, Inc. to provide BALVERSA 4MG. The place of performance is Carrollton, Texas. The period of performance is September 13-14, 2023. This delivery order supports the VA's mission to provide healthcare services to veterans through its Veterans Integrated Service Network...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded a $15,090.62 delivery order to Janssen Biotech, Inc. under the Pharmaceuticals and Drugs Federal Supply Schedule contract. The firm fixed price order is for BALVERSA 4MG and has a period of performance through November 6, 2020. No set-aside provisions were applied to this award made to support the VA's healthcare programs. Janssen Biotech will provide the requested pharmaceutical...
- Janssen Biotech, Inc. was awarded a $17,046.33 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) master contract vehicle by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 10. The firm fixed price order is for the drug BALVERSA 4MG and has a period of performance through May 12, 2023. No set-aside provisions were applied to this order. The Veterans Health Administration procures pharmaceuticals through...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded a $15,090.62 delivery order to Janssen Biotech, Inc. for BALVERSA 4 MG. The contract was issued against the Pharmaceuticals and Drugs Federal Supply Schedule, a multiple award schedule managed by the General Services Administration. Performance will take place in Carrollton, Texas. No set-aside provisions were applied to this firm fixed price order, which is scheduled for completion by...
- Janssen Biotech, Inc. was awarded a $17,046.33 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5. The firm fixed price order is for BALVERSA 4MG and has a period of performance through February 23, 2023. No set-aside provisions were applied to this award placed under GSA Schedule contract FSS-61-IB. The delivery order will provide needed pharmaceutical products to...
- Janssen Biotech, Inc. was awarded a $17,046.33 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5. The firm fixed price order is for BALVERSA 4MG and has a period of performance through June 9, 2023. No set-aside provisions were applied to this award placed under GSA Schedule contract FSS-61-IB. The delivery order will provide needed pharmaceutical supplies to...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded a $17,046 delivery order to Janssen Biotech, Inc. under the company's Pharmaceuticals and Drugs master contract (FSS-61-IB) on the General Services Administration schedule. The order is for BALVERSA RX and has a period of performance from November 24, 2023 through January 23, 2024. The firm fixed price order will be performed in Horsham, Pennsylvania by Janssen Biotech to supply the...